secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001104659-24-069063
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Voyager stockholders elect three Class III directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Michael Higgins, Jude Onyia, and Nancy Vitale elected Class III directors until 2027.
- Non-binding advisory vote on executive compensation passed with 35.9M for vs 1.7M against.
- Ratification of Ernst & Young as independent auditor for FY2024 with 46.3M for, 72K against.
- Broker non-votes of 8.6M on director elections and say-on-pay; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465924069063/0001104659-24-069063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465924069063/tm2416570d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-069063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer